International Clinical Trial: Single-arm exploratory study of glutamine combined with docetaxel in the treatment of KRAS G12D mutant advanced non-small cell lung cancer

Geneva, May 29 -- International Clinical Trials Registry received information related to the study (ChiCTR2600125260) titled 'Single-arm exploratory study of glutamine combined with docetaxel in the treatment of KRAS G12D mutant advanced non-small cell lung cancer' on May 24.

Study Type: Interventional study

Study Design: Single arm

Primary Sponsor: The Second Affiliated Hospital of Zhejiang University School of Medicine

Condition: Advanced Non-Small Cell Lung Cancer

Intervention: Trial group:Docetaxel 60-75 mg/m^2 intravenous infusion, Day 1, every 3 weeks

Recruitment Status: Not Recruiting

Phase: 2

Date of First Enrollment: 2026-05-24

Target Sample Size: Trial group:24;

Countries of Recruitment: China

To know more, vis...